Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
712.00    3.00 (0.42%)
Bid:
712.00
Ask:
713.00
Spread: 1.00 (0.14%)
Market Cap: £691.50m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Acquisition

12 Jan 2011 07:00

RNS Number : 3039Z
Acal PLC
12 January 2011
 



For Release

7.00am, 12 January 2011

 

Acal plc

 

Acal Strengthens Electronics Division with the Acquisition of

a German Specialist Electronics business

 

Acal plc (LSE: ACL, "The Group"), the pan European specialist provider of technology services, is pleased to announce the acquisition of 100% of CompoTRON GmbH ("CompoTRON"), for a maximum consideration of £7.1m (€8.5m) before expenses. CompoTRON has been acquired from BW-Holding GmbH, a company wholly owned by the CompoTRON management, Mr W Brack and Ms B Lohmaier.

CompoTRON is a specialist provider of electronic communication and fibre optic components to the European industrial electronic markets. Based in Munich with operations in Germany, the UK and Denmark, CompoTRON employs 22 staff. The company will form a separate business unit within Acal's Electronics division and will retain its strong independent brand identity.

 

The initial cash consideration of €6.8m (£5.7m) will be paid from the Group's existing cash resources. Additional deferred cash consideration of up to €1.7m (£1.4m) will be payable in January 2013 subject to the business achieving agreed performance targets over the next two years. Mr W Brack and Ms B Lohmaier will remain with the business and have committed to purchase 61,450 new ordinary shares in Acal plc at 270.5 pence per share, the average mid market closing price for the 5 days up to and including 10 January 2011.

 

CompoTRON's revenues for the year ended 31 December 2009 were €7.3m (£6.1m) and it generated a pre tax profit of €1.0m (£0.8m). Gross assets at 31 December 2009 were €2.2m (£1.8m). Forecast revenues for the year ended 31 December 2010 are approximately €10m (£8.3m), 37% ahead of the previous year. The acquisition is expected to be earnings enhancing on an underlying profits basis for the Group's year ended 31 March 2011.

 

Nick Jefferies, Chief Executive of Acal plc said:

 

"The acquisition of CompoTRON is a further step in the implementation of our European specialisation strategy, enhancing our position in the German specialist electronics market. It follows the acquisition of BFi Optilas in December 2009 which has now been successfully integrated into Acal. We are delighted to welcome CompoTRON into the Group."

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Cubitt Consulting

Chris Lane/Samantha Boston

01483 544500

 

 

 

020 7367 5100

 

Notes to Editors:

 

About Acal plc

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic and photonic products to industrial manufacturing and design companies. The Supply Chain Division supplies new and refurbished IT and EPOS spare parts to service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEANFFFLSFEFF
Date   Source Headline
28th Sep 20227:36 amRNSDirector Declaration
2nd Sep 202210:26 amRNSNotification of Major Holdings
1st Sep 202210:17 amRNSNotification of Major Holdings
26th Aug 20222:27 pmRNSNotification of Major Holdings
22nd Aug 202210:21 amRNSNotification of Major Holdings
29th Jul 20224:23 pmRNSNotification of Major Holdings
28th Jul 20223:00 pmRNSResults of Annual General Meeting
28th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSAcquisition of the CDT group
27th Jun 20223:44 pmRNSDirector / PDMR Shareholding
24th Jun 20221:00 pmRNSAnnual Report and Notice of AGM
24th Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20229:58 amRNSDirector LTIP Award
15th Jun 20228:03 amRNSNotification of Major Holdings
14th Jun 20227:00 amRNSPreliminary results
6th Jun 20227:00 amRNSNotice of Full Year Results
19th May 20222:38 pmRNSNotification of Major Holdings
11th May 20227:00 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202210:57 amRNSTR-1: Notification of Major Holdings
14th Apr 20227:00 amRNSFull Year Trading Update
7th Apr 20227:00 amRNSdiscoverIE Awarded “A” Rating by MSCI ESG
29th Mar 20224:29 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector Declaration
10th Mar 20223:02 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSHolding(s) in Company
4th Mar 20227:00 amRNSCompletion of Distribution Businesses Disposals
25th Feb 20229:50 amRNSDirector/PDMR Shareholding
9th Feb 20227:00 amRNSTrading Update
9th Feb 20227:00 amRNSChange to Operating Segments
10th Dec 20213:49 pmRNSDirector/PDMR Shareholding
8th Dec 20218:50 amRNSDirector/PDMR Shareholding
6th Dec 20218:30 amRNSIssue of Equity & Total Voting Rights
30th Nov 20217:00 amRNSInterim Results
22nd Nov 20214:05 pmRNSHolding(s) in Company
11th Nov 202112:49 pmRNSNotice of Half Year Results
9th Nov 20217:00 amRNSSale of Acal BFi Distribution Business
4th Nov 20217:00 amRNSAppointment of Non-Executive Director
14th Oct 20217:00 amRNSFirst Half Trading Update
4th Oct 20217:00 amRNSSale of Vertec SA
9th Sep 202110:44 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSResults of Placing
2nd Sep 20215:40 pmRNSAcquisitions & Proposed Placing
5th Aug 20215:30 pmRNSAggreko
30th Jul 20212:06 pmRNSDirector LTIP Award
29th Jul 20214:09 pmRNSResults of Annual General Meeting
29th Jul 20217:00 amRNSTrading Update
28th Jun 202110:09 amRNSHolding(s) in Company
25th Jun 20215:24 pmRNSDirector / PDMR Shareholding
16th Jun 202110:00 amRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.